Exclusive: Study in Brazil indicates Sinovac vaccine works against P1 variant found in Brazil – source

SAO PAULO (Reuters) – Preliminary data from a study in Brazil indicates that the COVID-19 vaccine developed by China’s Sinovac Biotech Ltd is effective against the P1 variant of the virus first discovered in Brazil, a source familiar with the study told Reuters on Monday.


By Eduardo Simões via Reuters


Read full article here

Share This

Chamber Updates Stay connected with Chamber activities